The oncology apoptosis modulators market, valued at USD 3.9 billion in 2022, is poised for significant growth, with projections indicating a robust compound annual growth rate (CAGR) of 11.1%. By 2032, the market is expected to reach a remarkable USD 8.4 billion. This growth is being propelled by the increasing demand for advanced cancer treatments …